News | May 24, 2011

Hologic Launches a Series of Hands-on Programs to Demonstrate 3-D Breast Tomosynthesis

May 24, 2011 - Hologic Inc. announced the first nine U.S. cities for a series of evening events to introduce clinicians to the Selenia Dimensions 2-D/3-D breast tomosynthesis system and gain hands-on experience with this new technology.

The Hologic system is the first commercial mammography system with breast tomosynthesis technology for breast cancer screening and diagnosis. The Selenia Dimensions system gives radiologists the option of offering their patients a 3-D tomosynthesis exam in addition to the conventional 2-D exam – all in one compression, in just seconds. In clinical studies Hologic submitted to the U.S. Food and Drug Administration (FDA), radiologists reading 2-D mammography plus 3-D breast tomosynthesis images compared to 2-D images alone demonstrated superior clinical performance in specificity, the confidence to rule out breast cancer without recalling the patient for further study, and also demonstrated improved sensitivity, the proportion of mammograms which include breast cancers that were correctly diagnosed.

Experts specializing in the areas of clinical image science, connectivity, medical education and managed care will participate in the Hologic events. The first leg of the U.S. tour will include the following cities:

- May 24th, Boston, Mass.
- June 14th, New York, N.Y.
- June 16th, Chicago, Ill
- July 12th, Seattle, Wash.
- July 14th, San Francisco, Calif.
- July 19th, Denver, Colo.
- July 21st, Dallas, Texas
- July 26th, Atlanta, Ga.
- July 28th, Tampa, Fla.

Radiologists, administrators, technologists, and other interested parties may register for the no-cost, first-of-its-kind events at www.hologic.com/tomoshows.

For more information: www.hologic.com

Related Content

VolparaDensity With Tyrer-Cuzick Model Improves Breast Cancer Risk Stratification
News | Breast Density | May 22, 2019
Research has demonstrated use of Volpara Solutions' VolparaDensity software in combination with the Tyrer-Cuzick Breast...
Managing Architectural Distortion on Mammography Based on MR Enhancement
News | Mammography | May 15, 2019
High negative predictive values (NPV) in mammography architectural distortion (AD) without ultrasonographic (US)...
Novel Artificial Intelligence Method Predicts Future Risk of Breast Cancer
News | Artificial Intelligence | May 08, 2019
Researchers from two major institutions have developed a new tool with advanced artificial intelligence (AI) methods to...
Georgia Becomes 38th State With Breast Density Inform Law
News | Breast Density | May 06, 2019
Georgia Gov. Brian Kemp signed breast density inform bill HB62 into law May 3, 2019. The law, which becomes effective...
American Society of Breast Surgeons Issues Risk-based Screening Mammography Guidelines
News | Mammography | May 03, 2019
The American Society of Breast Surgeons (ASBrS) has released the first screening mammography guidelines based on a...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...